Breaking Boundaries: Nexcella Inc., a Subsidiary of Immix Biopharma, to Showcase at Prestigious European Medical Conference

Breaking Boundaries: Nexcella Inc., a Subsidiary of Immix Biopharma, to Showcase at Prestigious European Medical Conference Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands February 9-11, 2023 LOS ANGELES, CA, Dec. 28, 2022 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…

Read More

Charmingly Eccentric: A Reader-Friendly Rewrite of Archaea Energy Inc. LFG Notice: Robbins LLP Reminds Investors of Investigation of the Acquisition of Archaea Energy Inc. by BP p.l.c. (BP)

Investigating the Acquisition of Archaea Energy Inc. by BP p.l.c Charmingly Eccentric and Full of Personality San Diego, Dec. 27, 2022 (GLOBE NEWSWIRE) Robbins LLP, a shareholder rights law firm, is currently conducting an investigation into the acquisition of Archaea Energy Inc. (NYSE: LFG) by BP p.l.c (NYSE: BP). The terms of the agreement state…

Read More

Revolutionizing Breast Cancer Treatment: Insilico Medicine’s AI-Powered Candidate Takes Aim at KAT6A for ER/HER2 Therapy

Insilico Medicine Nominates Preclinical Candidate Targeting KAT6A New York, Dec. 27, 2022 (GLOBE NEWSWIRE) — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company’s drug discovery team has nominated a preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy utilizing its end-to-end Pharma.AI platform. The Company has…

Read More

Tech Titans Unite: Global Tech Industries Group Inc. and Creatd Inc. in Talks for Epic Merger!

Tech Titans Unite: Global Tech Industries Group Inc. and Creatd Inc. in Talks for Epic Merger! New York, NY, Dec. 27, 2022 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII”), www.gtii-us.com, and Creatd, Inc. (CRTD: OTCQB) (“Creatd”), today announced that they have formally begun discussions to explore synergies, including a potential merger….

Read More

Attention Investors: Don’t Miss Out on the Deadline for Filing a Lead Plaintiff Motion in the Twist Bioscience Corporation Securities Class Action Lawsuit!

Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit Contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights NEW YORK, Dec. 27, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the…

Read More

Important Deadline for Gap Inc. Investors: Kessler Topaz Meltzer & Check LLP Reminds You of Securities Fraud Class Action Lawsuit

The Gap, Inc. Lawsuit: What Investors Need to Know Overview Recently, the law firm of Kessler Topaz Meltzer & Check, LLP has filed a securities class action lawsuit against The Gap, Inc. (NYSE: GPS) in the United States District Court for the Eastern District of New York. This lawsuit is a result of alleged securities…

Read More

2022 Cyber Confrontation: A Playful Peek into Kaspersky’s Uncovered Insights!

Kaspersky uncovers what cyber confrontation looked like in 2022 Woburn, MA, Dec. 26, 2022 (GLOBE NEWSWIRE) As part of Kaspersky’s annual Security Bulletin prediction series, experts analyzed cyberspace activities relating to the Ukrainian crisis, observing their meaning in relation to the current conflict, and their impact on the cybersecurity field. The story of the year,…

Read More